人工智能
机器学习
特征选择
稳健性(进化)
管道(软件)
优先次序
生物标志物发现
特征(语言学)
计算生物学
集成学习
计算机科学
鉴定(生物学)
数量结构-活动关系
计算模型
生物信息学
药物发现
系统生物学
生物网络
生物学数据
马尿酸
化学
生物标志物
深度学习
代谢稳定性
监督学习
作者
K. Liu,Ze-Yuan Liang,Tong Li,Lian-Zhi Cui,Jia‐Yi Wang,Zi‐Qi Shi,Gui-Zhong Xin
标识
DOI:10.1021/acs.analchem.6c00178
摘要
Intestinal barrier dysfunction is a pivotal factor in diverse pathologies, yet clear diagnostic criteria remain elusive, and biomarker discovery is often hindered by the high costs of large-scale clinical cohorts. Here, we developed a biologically informed machine learning (ML) pipeline that integrates function-guided network biology with ensemble feature selection (EFS) to identify key metabolic features associated with this condition. As an integrative framework, the pipeline combines knowledge-based screening and computational prioritization with biological validation, reconciling statistical rigor with biological interpretability. We first constructed a heterogeneous data set from multiphenotypic murine models and derived a continuous intestinal barrier index as a predicted variable. This approach reframes the conventional classification paradigm into a supervised regression task, enabling the discovery of disease-relevant clues without clear diagnostic end points. By leveraging network biology-informed EFS, we identified a functional feature subset of 10 core metabolites. The subset demonstrated remarkable stability across five distinct regression architectures, maintaining consistent robust performance ( R 2: 0.604–0.654; mean absolute error: 0.319–0.352). Furthermore, independent clinical validation coupled with in vitro biotransformation assays confirmed the applicability of these prioritized metabolic features, highlighting serotonin, N -acetylputrescine, d -phenylalanine, and hippuric acid as functional metabolic features of barrier dysfunction. In this work, ML was repurposed as a tool for feature prioritization, robustness evaluation, and hypothesis generation, reducing reliance on large cohorts. This integrated pipeline facilitates the identification of intestinal barrier dysfunction associated metabolic features and enables high-efficiency evaluation of multicomponent therapeutic responses, offering new insights into the management of complex multifactorial diseases.
科研通智能强力驱动
Strongly Powered by AbleSci AI